-
FDA approves liquid form of Merck HIV drug Isentress for infants, small children
WHITEHOUSE STATION, N.J. — The Food and Drug Administraiton has approved a liquid formulation of an HIV drug made by Merck, the company said.
Merck announced the approval of Isentress (raltegravir) for oral suspension, aimed at small children with HIV. The drug may be used by patients as young as four weeks, and the full line of formulations of Isentress now includes the orlal suspension, as well as chewable tablets and film--coated tablets. The company plans to launch the oral suspension in the third quarter of this year.
-
Maloof Ventures launches Never Hungover
LOS ANGELES — Maloof Ventures announced on Friday the launch of Never Hungover at GNC. Never Hungover is a dietary supplement that is comprised of a natural vitamin blend, antioxidants, amino acids, nutrients and minerals packaged as a 2-oz. serving.
The hangover shot is designed to take up to an hour before or while consuming alcohol, and experiences optimal results when taking one bottle per four drinks.